Delivery Order SPE2DB25D3110-SPE2DB25FTDCU
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,715.83 on July 29, 2025, for the supply of Fluticasone Propionate HFA 44 microgram inhalers (10.6 grams). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $4,557.00 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 mcg inhalers (12 grams) on July 17, 2025, with an ultimate completion date of July 18, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, valued at $1,184.52, with an ultimate completion date of August 4, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,545.00 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 MCG 12GM inhalers. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 4, 2025. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,108.90 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams), with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $42,827.06 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 microgram inhalers (12-gram units) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $1,699.69 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Fluticasone Propionate HFA 110 MCG 12GM inhalers. This contract utilizes firm fixed pricing with an ultimate completion date of September 15, 2025, and was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $2,532.00 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 mcg inhalers (12 grams). This competitively awarded, firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a standard pharmaceutical procurement under the company's...
- The U.S. Defense Medical Supply Chain awarded a $1,184.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 mcg inhalers (12 grams) on July 30, 2025, with completion targeted for July 31, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a $1,189.40 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 mcg inhalers (12-gram units) on June 20, 2025, with a completion date of June 23, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTDCUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,665.66 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 MCG 12GM inhalers. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with performance completed at AmerisourceBergen's Conshohocken, Pennsylvania location and an ultimate completion date of April 24, 2025. The delivery order was awarded on April 23, 2025, as part of the company's broader relationship with the federal government as a major pharmaceutical and medical supply distributor. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. AmerisourceBergen serves as a critical pharmaceutical prime vendor for the Defense Logistics Agency's Medical Supply Chain, supplying a comprehensive range of medications, vaccines, and medical supplies to support military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical procurement requirements competitively, serving customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 4/23/25 |